Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Javier Garcia-Corbacho"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hendrik-Tobias Arkenau, Vanessa Huels, Fiona C Thistlethwaite, Nataliya Volodymyrivna Uboha, Bert H. O'Neil, Beverly A. Benson, William J. Garner, Omid Hamid, Javier Garcia-Corbacho, Javier Lavernia, Ferry A.L.M. Eskens, Manreet Randhawa, Anthony B. El-Khoueiry, Aung Naing, Patricia LoRusso, Alexander I. Spira
Publikováno v:
Journal of Clinical Oncology. 37:2513-2513
2513 Background: Anti-programmed cell death ligand 1 (PD-L1) immunotherapies have improved survival in many cancers, but immune-related adverse events (irAEs) have been observed, especially in combination therapy. CX-072 is an investigational Probody
Autor:
S. Agarwal, S. Ponce Aix, Sun Young Rha, A. Lazorchak, Erika Hamilton, Y.-J. Bang, T. Wyant, A. Ma, M. Gil Martin, John D. Powderly, J. Brody, K-P. Kim, F. Meric-Bernstam, David Tuck, M-J. Ahn, M.R. Patel, James J. Lee, Javier Garcia-Corbacho, Adil Daud, Huaibin Wang
Publikováno v:
Annals of Oncology. 28:v405-v406
Autor:
Rachel Humphrey, Fiona C Thistlethwaite, Beiyao Zheng, Elisabeth G.E. de Vries, Javier Garcia Corbacho, Anthony B. El-Khoueiry, Matthias Will, Karen A. Autio, Rachel E. Sanborn, Morganna Freeman, Elizabeth Ruth Plummer, Vanessa Huels, Nataliya Volodymyrivna Uboha, Catharina Wilhelmina Menke, Patricia LoRusso, Hendrik-Tobias Arkenau, Jerzy Wydmański
Publikováno v:
Journal of Clinical Oncology. 36:3072-3072
3072Background: CX-072 is a Pb-Tx directed against programmed cell death ligand 1 (PD-L1), designed to be preferentially activated by tumor-associated proteases but not in healthy tissue. Preclinic...
Autor:
Begoña Mellado, Laia Paré, Manel Juan, Barbara Adamo, Carme Font, Victoria Sanchez, Nuria Viñolas, Noemi Reguart, Montserrat Muñoz, Juan Maurel, Daniel Benitez, Mercedes Marín-Aguilera, Margarita Viladot, Cristina Nadal, Elia Seguí, Estela Pineda, Núria de la Iglesia, Aleix Prat, Òscar Reig, Javier Garcia Corbacho
Publikováno v:
Journal of Clinical Oncology. 34:3033-3033
3033Background: Immune infiltration predicts survival in particular cancer-types. However, differences in immune profiling and associations with patient outcomes among multiple cancer-types have no...